GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » EV-to-Revenue

U2Bio Co (XKRX:221800) EV-to-Revenue : 0.50 (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, U2Bio Co's enterprise value is ₩15,287 Mil. U2Bio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩30,792 Mil. Therefore, U2Bio Co's EV-to-Revenue for today is 0.50.

The historical rank and industry rank for U2Bio Co's EV-to-Revenue or its related term are showing as below:

XKRX:221800' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.07   Med: 1.7   Max: 5.5
Current: 0.5

During the past 9 years, the highest EV-to-Revenue of U2Bio Co was 5.50. The lowest was 0.07. And the median was 1.70.

XKRX:221800's EV-to-Revenue is ranked better than
90.58% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs XKRX:221800: 0.50

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), U2Bio Co's stock price is ₩4500.00. U2Bio Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,027.98. Therefore, U2Bio Co's PS Ratio for today is 1.49.


U2Bio Co EV-to-Revenue Historical Data

The historical data trend for U2Bio Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co EV-to-Revenue Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 1.54 0.79 1.19 0.42 0.76

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
EV-to-Revenue - 0.42 - 0.76

Competitive Comparison of U2Bio Co's EV-to-Revenue

For the Diagnostics & Research subindustry, U2Bio Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U2Bio Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where U2Bio Co's EV-to-Revenue falls into.



U2Bio Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

U2Bio Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=15286.980/30792.036
=0.50

U2Bio Co's current Enterprise Value is ₩15,287 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U2Bio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩30,792 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U2Bio Co  (XKRX:221800) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

U2Bio Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4500.00/3027.975
=1.49

U2Bio Co's share price for today is ₩4500.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,027.98.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U2Bio Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of U2Bio Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines